Ács, N.; Korte, W.C.; von Heymann, C.C.; Windyga, J.; Blatný, J.
Rationale for the Potential Use of Recombinant Activated Factor VII in Severe Post-Partum Hemorrhage. J. Clin. Med. 2024, 13, 2928.
https://doi.org/10.3390/jcm13102928
AMA Style
Ács N, Korte WC, von Heymann CC, Windyga J, Blatný J.
Rationale for the Potential Use of Recombinant Activated Factor VII in Severe Post-Partum Hemorrhage. Journal of Clinical Medicine. 2024; 13(10):2928.
https://doi.org/10.3390/jcm13102928
Chicago/Turabian Style
Ács, Nándor, Wolfgang C. Korte, Christian C. von Heymann, Jerzy Windyga, and Jan Blatný.
2024. "Rationale for the Potential Use of Recombinant Activated Factor VII in Severe Post-Partum Hemorrhage" Journal of Clinical Medicine 13, no. 10: 2928.
https://doi.org/10.3390/jcm13102928
APA Style
Ács, N., Korte, W. C., von Heymann, C. C., Windyga, J., & Blatný, J.
(2024). Rationale for the Potential Use of Recombinant Activated Factor VII in Severe Post-Partum Hemorrhage. Journal of Clinical Medicine, 13(10), 2928.
https://doi.org/10.3390/jcm13102928